Skip to content
Drug Policy Watch™
LatestTracking drug policy in all 50 states and Congress, updated every morning.See all ›
Drug Policy Watch · State Brief 2026

Minnesota

Snapshot (structured)

Adult-use cannabis
Legal. Legalized 2023 (HF 100). Licensed adult-use retail sales began September 17, 2025.
Medical cannabis
Legal. Program established 2014, now run by the Office of Cannabis Management (OCM); roughly 19 qualifying conditions.
Home grow
Allowed. Up to 8 plants per residence, no more than 4 mature/flowering, in an enclosed locked space.
Intoxicating hemp / hemp THC
Legal and regulated. Distinctive low-dose hemp THC edible and beverage market (legalized 2022), now under OCM (Chapter 342). Edible serving limit 5 mg, beverages 10 mg per container historically; caps revised upward in the 2026 omnibus.
Psychedelics
Illegal. State Psychedelic Medicine Task Force recommended a regulated psilocybin therapy program; the 2025-2026 session created no therapy program, enacting only an OCM psilocybin feasibility study with a report due January 15, 2027.
Broad decriminalization
No general drug decriminalization. Cannabis legal; other controlled substances remain criminal.
Harm reduction
Strong. Syringe services and naloxone access supported by state grants; drug-checking supplies including fentanyl test strips legalized; Good Samaritan overdose law in effect.
Governor (party)
Tim Walz (DFL / Democratic).
Legislature control
Split. Senate DFL majority (about 34-33); House tied 67-67 under a power-sharing agreement with Republican Speaker Lisa Demuth.
Citizen ballot initiatives allowed
No. Minnesota has no citizen initiative or referendum; only the legislature can refer constitutional amendments.
Enclosure pressure score
3/5

Cannabis

Minnesota legalized adult-use cannabis in 2023 when Governor Walz signed HF 100, making it the 23rd state to do so. Adults 21 and older may possess up to 2 ounces of flower in public and up to 2 pounds at home, and may grow cannabis at home (see Home grow). The retail market took roughly two years to stand up: OCM began accepting license applications in January 2025, ran lotteries for capped license types in mid-2025, and licensed adult-use retail sales began September 17, 2025, initially through medical dispensaries operating under combination licenses and a Tribal microbusiness. (https://mjbizdaily.com/recreational-cannabis-sales-begin-in-minnesota/) By year-end 2025, OCM reported it had issued 118 full cannabis licenses and granted roughly 1,405 preliminary approvals, with about $31.1 million in adult-use sales since launch. (https://mjbizdaily.com/recreational-cannabis-sales-begin-in-minnesota/)

Medical cannabis has operated since 2014 and is now administered by OCM's Division of Medical Cannabis. The state does not issue physical cards; patients enroll in an online Medical Cannabis Registry after certification by a Minnesota provider, and veterans may self-certify. There are roughly 19 qualifying conditions. (https://mn.gov/ocm/dmc/patients/the-basics/how-to-become-a-patient.jsp) (https://mn.gov/ocm/dmc/patients/the-basics/qualifying-medical-condition.jsp)

Market structure: Minnesota's design is unusually structured to limit consolidation. The original law set numerical license caps on several license types, created a microbusiness and Tribal pathway, and was widely described as restricting heavy vertical integration outside of medical operators. The 2026 cannabis omnibus changed this significantly. On May 26, 2026, Governor Walz signed a roughly 105-page cannabis omnibus bill (SF 4401 / HF 4203) that creates a new "macrobusiness" license allowing certain operators to combine cultivation, manufacturing, retail, and other endorsements under one license, and that merges the previously bifurcated medical and adult-use supply chains, letting a medical-endorsed business serve both patients and adult-use customers from one operation. (https://foleyhoag.com/news-and-insights/blogs/cannabis-and-the-law/2026/may/minnesota-governor-walz-signs-landmark-cannabis-omnibus-bill-reshaping-state-s-cannabis-industry/) (https://www.house.mn.gov/sessiondaily/Story/19196)

Taxes: Cannabis carries a state cannabis gross receipts tax that was raised from 10 percent to 15 percent effective for sales after June 30, 2025, on top of the 6.875 percent state sales tax, for a minimum combined rate of roughly 22 percent before any local tax. Medical cannabis is exempt from the gross receipts tax. (https://www.revenue.state.mn.us/cannabis-tax) (https://news.bloombergtax.com/daily-tax-report-international/minnesota-dor-increases-cannabis-tax-rate-alters-revenue-allocation)

Key 2026 actions: passage and signing of the cannabis omnibus (macrobusiness license, supply-chain merger, raised hemp/edible mg caps, local-certification backstop allowing OCM to license when a local government misses a 30-day window). (https://foleyhoag.com/news-and-insights/blogs/cannabis-and-the-law/2026/may/minnesota-governor-walz-signs-landmark-cannabis-omnibus-bill-reshaping-state-s-cannabis-industry/) (https://marijuana.school/minnesotas-new-2026-cannabis-omnibus-bill/)

Hemp

Minnesota is the standout state for a legal, retail-scale low-dose hemp THC market. The legislature legalized hemp-derived THC edibles and beverages in 2022, creating a Lower-Potency Hemp Edible (LPHE) category sold widely in liquor stores, breweries, taprooms, and groceries. Regulation moved under OCM via Chapter 342. Historic product limits were 5 mg THC per serving and 50 mg per package for edibles and 10 mg per container for beverages. (https://twin-cities.umn.edu/news-events/updates-hemp-derived-thc-minnesota) New OCM testing and labeling rules phase in through 2026: until the end of 2025 licensees could sell under old or new rules, and starting in 2026 new products must meet the new rules while older tested stock can sell through. (https://content.govdelivery.com/accounts/MNMDH/bulletins/35dfcc5) Industry groups warned the new testing and labeling requirements could harm beverage makers. (https://www.startribune.com/thc-drink-makers-worried-new-testing-labeling-rules-minnesota-law-hemp-marijuana/601483453) The 2026 omnibus raised some milligram caps for food and beverage products. (https://marijuana.school/minnesotas-new-2026-cannabis-omnibus-bill/)

Federal exposure: A new federal hemp definition with an effective date of November 12, 2026 would cap finished hemp-derived THC products at roughly 0.4 mg per container, which would functionally outlaw Minnesota's LPHE products as currently sold and threaten a market estimated in the range of $180-210 million. Reporting indicates OCM intends to continue implementing Chapter 342 under state law regardless of the federal enforcement date, since state law does not automatically defer to the federal standard; how a state-versus-federal conflict resolves is unconfirmed. (https://www.carpfishcreative.com/post/mn-canna-may5) The November 12, 2026 federal deadline is the single biggest watch item for this market.

Psychedelics

Psilocybin, MDMA, and LSD remain illegal under Minnesota law as of June 2026. The Minnesota Department of Health convened a Psychedelic Medicine Task Force, which in a 2025 report recommended the legislature establish a state-regulated program for therapeutic administration of psilocybin-containing mushrooms. (https://www.health.state.mn.us/people/psychmed/index.html)

2026 bills (94th Legislature, 2025-2026 biennium): - HF 2699 would create a framework for legal cultivation, possession, transportation, and personal use of psilocybin by adults 21+, with public-education and harm-reduction programs and a Psychedelic Medicine Board. (https://www.revisor.mn.gov/bills/94/2025/0/HF/2699/versions/latest/) - A separate veterans-focused bill carried by Rep. Max Rymer (R-North Branch) would authorize limited therapeutic psilocybin use for adults 21+, capped at no more than 1,000 patients in the first three years. (https://www.kaxe.org/minnesota-news/2026-04-20/psychedelic-mushrooms-legalized-therapy-minnesota)

Neither bill was enacted. The 2025-2026 session ended without creating a psilocybin therapy program; instead the legislature enacted an OCM psilocybin feasibility study, with a report due January 15, 2027. (https://minnesotareformer.com/2026/07/10/minnesota-is-on-the-verge-of-expanding-access-to-psilocybin-therapy/)

Broader drug policy

Decriminalization: No general decriminalization of controlled substances beyond cannabis. Minnesota has not adopted an Oregon-style possession decriminalization.

Harm reduction: Minnesota is among the more permissive states. It is reported to have removed drug paraphernalia from criminalization, including testing equipment and syringes, making drug-checking supplies such as fentanyl test strips legal. (https://www.astho.org/communications/blog/harm-reduction-policies-can-prevent-overdose-fatalities/) The state health commissioner can award grants for syringe access, sterile injection equipment, naloxone, and fentanyl test strips, and Minnesota requires private insurance to cover at least one opioid antagonist. (https://www.astho.org/communications/blog/harm-reduction-policies-can-prevent-overdose-fatalities/) A Good Samaritan law shields people who seek help during an overdose from certain drug-possession charges. (https://www.astho.org/communications/blog/harm-reduction-policies-can-prevent-overdose-fatalities/) Minnesota Management and Budget released a Naloxone Saturation Strategy in February 2025. (https://mn.gov/mmb/assets/naloxone-saturation-strategy-2025_tcm1059-671241.pdf)

Sentencing and expungement: see Equity and expungement. Cannabis legalization paired with one of the largest automatic-expungement efforts in the country, and Minnesota's broader Clean Slate Act took effect January 1, 2025. (https://www.recordinglaw.com/us-laws/expungement/minnesota-expungement-laws/)

Political landscape

Governor: Tim Walz (DFL), seeking what would be an unprecedented third term in 2026; Republican House Speaker Lisa Demuth is running against him. (https://www.cbsnews.com/minnesota/news/lisa-demuth-running-for-minnesota-governor/)

Legislature: Closely divided, with the full legislature about 101 DFL to 100 Republican. (https://www.minnpost.com/state-government/2026/01/from-anoka-to-the-iron-range-a-preview-of-minnesota-legislative-battlegrounds-in-2026/) The Senate has a one-seat DFL majority (about 34 DFL, 33 Republican). (https://www.house.mn.gov/sessiondaily/Story/18428) The House is tied 67-67 and operates under a power-sharing agreement: Republican Rep. Lisa Demuth (Cold Spring) holds the speakership while both parties co-chair most committees. (https://minneapolimedia.town.news/g/coon-rapids-mn/n/363804/minnesota-house-restored-even-split-two-new-dfl-lawmakers-are-sworn)

Reform champions: Rep. Jessica Hanson (DFL) and Sen. D. Scott Dibble (DFL) carried the 2026 cannabis omnibus. (https://fastdemocracy.com/bill-search/mn/2025-2026/bills/MNB00064271/) Rep. Max Rymer (R-North Branch) is the named champion of veterans-focused psilocybin therapy. (https://www.kaxe.org/minnesota-news/2026-04-20/psychedelic-mushrooms-legalized-therapy-minnesota) Named, specific opponents of cannabis or psychedelic reform in 2026: unconfirmed.

Key committees: cannabis and commerce-related committees in each chamber handle these bills; specific 2026 committee chairs are unconfirmed here given the co-chair power-sharing structure.

Ballot initiatives

Minnesota does not allow citizen-initiated statewide ballot measures. Voters cannot place statutes or initiatives on the ballot; the only statewide direct-democracy mechanism is a legislatively referred constitutional amendment, which requires a majority in each chamber and then a majority of all ballots cast in the election. (https://ballotpedia.org/Laws_governing_ballot_measures_in_Minnesota) Voters rejected proposals to create an initiative process in 1914, 1916, and 1980. (https://ballotpedia.org/Laws_governing_ballot_measures_in_Minnesota) Consequently there are no pending citizen cannabis or psychedelic ballot measures; all reform runs through the legislature.

Equity and expungement

The legalization law gives licensing preferences to social-equity applicants, including residents of areas that experienced disproportionate cannabis enforcement. (https://www.marijuanamoment.net/minnesota-lawmakers-to-revisit-marijuana-laws-expungement-provisions-that-make-it-hard-to-prove-social-equity-business-status/)

Expungement is automatic for low-level cannabis offenses. The Bureau of Criminal Apprehension (BCA) automatically seals records for small-amount cannabis offenses that became legal, completing an initial round on May 13, 2024 that sealed 57,780 records, then expanding under the broader Clean Slate Act. (https://dps.mn.gov/news/bca/adult-use-cannabis-act-automatic-expungements-bca-records-complete) (https://www.marijuanamoment.net/more-than-57000-marijuana-records-have-been-automatically-expunged-under-minnesotas-legalization-law-officials-announce/) The Clean Slate Act took effect January 1, 2025. (https://www.recordinglaw.com/us-laws/expungement/minnesota-expungement-laws/) By April 14, 2026, BCA reported it had expunged roughly 1.57 million of about 2.03 million eligible records, around 94 percent complete. (https://dps.mn.gov/news/bca/adult-use-cannabis-act-automatic-expungements-bca-records-complete)

Tension to watch: because records are sealed automatically, some social-equity applicants have found it harder to document the prior arrests/convictions that would prove their equity status, and lawmakers have signaled they would revisit these provisions. (https://www.marijuanamoment.net/minnesota-lawmakers-to-revisit-marijuana-laws-expungement-provisions-that-make-it-hard-to-prove-social-equity-business-status/)

Market and barriers

Enclosure read

Minnesota started near the "open" end of the spectrum by design: low-dose hemp THC was widely available through ordinary retail, home grow is generous (8 plants), expungement is automatic and large-scale, harm reduction is among the most permissive in the country, and the original cannabis law favored microbusinesses, Tribal operators, and social-equity applicants while limiting vertical integration. That pushed toward openness.

The 2026 omnibus moves the needle toward consolidation. The new macrobusiness license and the merger of the medical and adult-use supply chains advantage well-capitalized, vertically integrated operators (including existing medical MSOs) and make it easier for larger firms to combine cultivation, manufacturing, and retail. Meanwhile the looming November 12, 2026 federal hemp cap threatens to fence out the broad base of small hemp-beverage and edible sellers (liquor stores, breweries, independents) that defined Minnesota's open market, potentially channeling that demand into the licensed, more concentrated cannabis system. The expungement-versus-equity-proof tension also quietly fences out some intended equity beneficiaries.

Net read: still meaningfully open relative to many states, but with clear 2026 consolidation pressure layered on top of a structurally open foundation. Score: 3/5.

What to watch next

Regulators

Federal exposure (2026)

Minnesota sits at the most exposed end of the 2026 federal landscape, because the federal lever that matters most here is not cannabis rescheduling but hemp.

Rescheduling and 280E. Cannabis remains Schedule I by default. The DOJ/DEA order signed April 22, 2026 and effective April 28, 2026 (91 FR 22714) moved only FDA-approved cannabis drugs and state-licensed medical cannabis to Schedule III; adult-use (recreational) cannabis stays Schedule I. For Minnesota this means the state's medical cannabis operators, now run through OCM's Division of Medical Cannabis, gain the practical benefit of escaping IRC Section 280E, so medical-side margins improve. The adult-use market that opened to retail on September 17, 2025 gets no 280E relief and continues to face the full federal tax penalty (no ordinary business deductions), on top of Minnesota's roughly 22 percent combined state tax burden. The broader DEA rescheduling hearing opened June 29, 2026 and may slip to 2027; Schedule III does not legalize cannabis, does not authorize interstate commerce, and does not cover state recreational businesses, so it does not relieve Minnesota's adult-use sector. (https://foleyhoag.com/news-and-insights/blogs/cannabis-and-the-law/2026/may/minnesota-governor-walz-signs-landmark-cannabis-omnibus-bill-reshaping-state-s-cannabis-industry/)

The November 12, 2026 hemp cliff (critical for Minnesota). This is the single most consequential federal exposure for the state. FY2026 agriculture appropriations (Sec. 781, sponsored by Rep. Andy Harris, R-MD) narrowed the federal hemp definition to a total-THC standard of roughly 0.4 mg THC per container, recriminalizing an estimated 90 to 95 percent of intoxicating hemp products effective November 12, 2026. A proposed H.R.7010 delay was not enacted, and the 2026 Farm Bill (H.R.7567) keeps the ban. Minnesota is uniquely exposed because it built the country's flagship legal low-dose hemp THC edible and beverage market: products sold openly in liquor stores, breweries, taprooms, and groceries at 5 mg per serving (edibles) and 10 mg per container (beverages), with caps revised upward in the 2026 omnibus. Practical effect: a 0.4 mg per-container federal cap is roughly one twenty-fifth of a standard 10 mg Minnesota THC beverage, so essentially every Minnesota hemp-THC seltzer, edible, and beverage on the market would fall outside the federal hemp definition and be reclassified as federally controlled marijuana once the cliff hits. That threatens a market estimated in the range of $180 to 210 million and the breweries and distributors built around it; reporting in June 2026 warned the ban could wipe out some Minnesota breweries and drink distributors. (https://www.mprnews.org/story/2026/06/16/minnesota-breweries-could-be-wiped-out-by-upcoming-hemp-thc-ban) (https://www.cbsnews.com/minnesota/news/hemp-thc-federal-changes-business-impact/) (https://www.startribune.com/5-things-thc-drinkers-minnesota-should-know-about-federal-ban-hemp-beverages-utepils-indeed-lobby/601528733) OCM has signaled it intends to keep implementing Chapter 342 under state law regardless of the federal enforcement date, since state law does not automatically defer to the federal standard; how a direct state-versus-federal conflict resolves is unconfirmed, but the federal change criminalizes interstate movement, banking, and payment processing for these products regardless of what Minnesota does internally. (https://www.carpfishcreative.com/post/mn-canna-may5)

Banking. SAFER Banking remains stalled in Congress. Both Minnesota's adult-use cannabis operators and, after November 12, its hemp-THC sellers face the standard problem of limited access to mainstream banking, card payment rails, and ordinary lending, which structurally advantages well-capitalized incumbents that can self-finance over small and social-equity operators.

Psychedelics. Psilocybin, MDMA, and ibogaine remain Schedule I federally. The April 18, 2026 executive order, Accelerating Medical Treatments for Serious Mental Illness [https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/] plus FDA priority vouchers fast-track FDA review, but there is no federal approval yet. Minnesota's 2026 psilocybin bills (HF 2699, and the veterans-focused bill carried by Rep. Max Rymer, R-North Branch) were not enacted; the session produced only an OCM psilocybin feasibility study (report due January 15, 2027), not a therapy program. Any state therapeutic-psilocybin program would still run into the federal Schedule I status of the substance, so the realistic near-term path is the federal FDA pathway rather than the state route. (https://www.kaxe.org/minnesota-news/2026-04-20/psychedelic-mushrooms-legalized-therapy-minnesota)

Fentanyl. The HALT Fentanyl Act (signed July 17, 2025) permanently placed fentanyl-related substances in Schedule I; this is a national baseline and does not turn on Minnesota's relatively permissive posture.

Harm reduction. Minnesota runs among the most permissive harm-reduction regimes in the country, and that is precisely what makes it exposed to the federal cut: SAMHSA guidance issued April 24, 2026 bars federal funds from being used for fentanyl test strips, clean syringes, and sterile water; naloxone remains federally supported. Minnesota legalized drug-checking supplies including fentanyl test strips and authorizes state grants for syringe access, sterile injection equipment, naloxone, and test strips. The federal change does not make any of these illegal in Minnesota, but it pulls federal dollars away from the syringe-services, test-strip, and sterile-water components, shifting that funding burden onto the state and local grantees while leaving the naloxone-saturation work (per the February 2025 Naloxone Saturation Strategy) federally fundable. (https://www.astho.org/communications/blog/harm-reduction-policies-can-prevent-overdose-fatalities/) (https://mn.gov/mmb/assets/naloxone-saturation-strategy-2025_tcm1059-671241.pdf)

Patient access and rights

This section covers what Minnesota law does and does not protect for a medical cannabis patient: use inside a hospital, and the broader rights that follow a patient into work, housing, parenting, an organ transplant list, and school. It is information, not legal advice, and it reflects the law as of July 2026. Each point links to the primary statute.

Hospital access (Ryan's Law): Minnesota has no hospital-access law. No statute requires a hospital, nursing home, or hospice to let a qualifying patient use medical cannabis on site, so whether a facility allows it is left to that facility's own policy, and many refuse. Seven states have now enacted a Ryan's Law protection (California in 2021, and Colorado, Delaware, Louisiana, Oregon, Virginia, and Washington in 2026), and Pennsylvania has a bill pending; Minnesota is not among them. The absence is the finding: a Minnesota patient has no enforceable right to use their medicine in a hospital today.

Broader protections: here Minnesota is comparatively strong. A single statute, Minnesota Statutes Section 342.57 (recodified from the earlier Section 152.32), protects an enrolled patient across all six areas. It bars employment discrimination against a registered patient (subdivision 5), bars a landlord or a school from refusing a person solely for being enrolled (subdivision 3), protects custody and parenting time absent a showing of danger to the child (subdivision 6), and provides that for the purposes of medical care, including organ transplants, authorized use is treated as the equivalent of any other prescribed medication (subdivision 4). A Minnesota patient cannot be denied a transplant listing solely for lawful medical cannabis use.

Out-of-state patients: Minnesota does not recognize out-of-state medical cards; a patient must be enrolled in the Minnesota program and purchase at a Minnesota dispensary.

The federal picture: the April 2026 federal move of state-licensed medical cannabis to Schedule III did not change any of this. Schedule III does not make dispensary cannabis a lawful prescription medicine and does not create any hospital-use right; only state law can force hospital access, and Minnesota has not enacted a Ryan's Law. The broader protections above are a creature of Minnesota law, not federal law.

Sources: Minnesota patient protections, Minnesota Statutes Section 342.57.

Related reading from Drug Policy Watch: the Federal Drug Policy Brief, the Schedule III rescheduling explainer, and the 50-State Matrix.

Analysis: the enclosure read in depth

Who gets fenced out, and who consolidates. Minnesota's distinctiveness is that it built a genuinely open foundation, then layered two enclosure forces on top in 2026: one state, one federal.

On the state side, the May 26, 2026 cannabis omnibus (SF 4401 / HF 4203) creates a new vertically integrated "macrobusiness" license that lets certain operators combine cultivation, manufacturing, retail, and other endorsements under one license, and it merges the previously bifurcated medical and adult-use supply chains so a medical-endorsed business can serve both patients and adult-use customers from one operation. (https://foleyhoag.com/news-and-insights/blogs/cannabis-and-the-law/2026/may/minnesota-governor-walz-signs-landmark-cannabis-omnibus-bill-reshaping-state-s-cannabis-industry/) (https://www.house.mn.gov/sessiondaily/Story/19196) The original 2023 law had deliberately limited vertical integration and favored microbusinesses, Tribal operators, and social-equity applicants; the macrobusiness license and the supply-chain merger move in the opposite direction, advantaging well-capitalized, vertically integrated firms (including existing medical MSOs that just gained 280E relief federally) and pushing the market toward consolidation. Who consolidates: incumbent medical operators and large multi-endorsement firms. Who is fenced out at the margin: the smaller microbusiness and standalone operators that the original caps were designed to protect, and the social-equity applicants who, separately, struggle to document their qualifying prior records because automatic expungement sealed them.

On the federal side, the November 12, 2026 hemp cliff is the heavier enclosure force, and it lands hardest on the broadest, most decentralized layer of Minnesota's market: the liquor stores, breweries, taprooms, and independent grocers selling 5 mg and 10 mg hemp-THC products. The state-plus-federal interaction is the key dynamic: even if OCM keeps licensing and enforcing Chapter 342 internally, federal recriminalization of interstate commerce, banking, and payments for these products squeezes out the small, dispersed sellers and channels intoxicating-THC demand into the licensed, more concentrated, more capital-intensive cannabis system, where the macrobusiness incumbents sit. In other words, the two 2026 forces reinforce each other: federal enclosure of hemp pushes demand toward the licensed channel, and state consolidation in that licensed channel determines who captures it. The federal posture (Republican Congress, medicalize-and-control) favors large incumbents and fences out small actors and hemp, and Minnesota is the clearest state-level illustration of that read.

Commons counter-moves present. Two genuine openings remain. First, generous home grow: up to 8 plants per residence (no more than 4 mature) keeps a non-market, household-scale supply lane open that no license consolidation or federal hemp cap can close. Second, automatic, large-scale expungement: roughly 1.57 million of about 2.03 million eligible records expunged (around 94 percent) by April 14, 2026 under the cannabis act and the Clean Slate Act, which is a durable commons gain even though it created the equity-proof tension noted above. (https://dps.mn.gov/news/bca/adult-use-cannabis-act-automatic-expungements-bca-records-complete) Permissive harm reduction is a third openness marker, though it is now partly exposed to the SAMHSA funding cut.

What to watch. Whether OCM holds its line on Chapter 342 after November 12, 2026 and how any state-federal conflict resolves; the rollout of the macrobusiness license and supply-chain merger and whether OCM rulemaking preserves the microbusiness and social-equity lanes; whether Congress enacts any hemp delay or carve-out before the cliff; and the 2026 elections (Walz vs. Demuth, all 201 legislative seats), which set 2027 prospects.

Justifying the score. The enclosure score stays 3/5. The foundation is genuinely open (home grow, automatic expungement, permissive harm reduction, an originally anti-consolidation license design, and the nation's broadest legal low-dose hemp retail market), which holds the score below the consolidated end. But the 2026 macrobusiness license and supply-chain merger introduce real state-level consolidation, and the November 12, 2026 federal hemp cliff threatens to dismantle the single most open feature of the market and redirect that demand into the more concentrated licensed system. Those two forces, reinforcing each other, justify a midpoint read rather than a low one: still meaningfully open, but under clear and converging consolidation pressure. Score: 3/5.

Active legislation (2026)

Note: The 2026 regular session adjourned in May 2026, so most items below are recently enacted or carried over from the 2025-2026 biennium rather than pending. This list is not exhaustive; for the long tail see the Minnesota Revisor bill search and LegiScan.

Beyond the live tracker

These measures are not in the live bill list below: some are not bills (executive orders, rules, referendums, or budgets), and some are proposals or prior-session measures the live tracker does not currently carry.

  • Veterans psilocybin therapy bill (bill number unconfirmed) Limited therapeutic psilocybin for veterans/adults 21+, capped at 1,000 patients first 3 years (Introduced/advancing 2026; not enacted)
  • Medical home-grow expansion proposal (bill number unconfirmed) Would double home-grow plant count for medical patients (Proposed 2026; status unconfirmed)
Bill Title/Topic Chamber Status Sponsor(s)
SF 4401 / HF 4203 Cannabis omnibus: macrobusiness license, medical/adult-use supply-chain merger, raised hemp/edible mg caps, local-certification backstop Senate / House Signed by Gov. Walz May 26, 2026 Sen. D. Scott Dibble; Rep. Jessica Hanson (House companion); cosponsors incl. Sen. Lindsey Port (per FastDemocracy/MarijuanaHerald) (https://fastdemocracy.com/bill-search/mn/2025-2026/bills/MNB00064271/)
HF 2699 Psilocybin legalization framework for adults 21+, Psychedelic Medicine Board House Not enacted. Update, July 18, 2026: the 2025-2026 session ended without a psilocybin therapy program; instead an Office of Cannabis Management psilocybin feasibility study was enacted, with a report due January 15, 2027. (source) Listed on the bill page at revisor.mn.gov; primary author per that page (https://www.revisor.mn.gov/bills/94/2025/0/HF/2699/?body=house)
Veterans psilocybin therapy bill (bill number unconfirmed) Limited therapeutic psilocybin for veterans/adults 21+, capped at 1,000 patients first 3 years House Introduced/advancing 2026; not enacted Rep. Max Rymer (R-North Branch) (https://www.kaxe.org/minnesota-news/2026-04-20/psychedelic-mushrooms-legalized-therapy-minnesota)
Medical home-grow expansion proposal (bill number unconfirmed) Would double home-grow plant count for medical patients unconfirmed Proposed 2026; status unconfirmed unconfirmed (https://www.cbsnews.com/minnesota/news/minnesota-medical-cannabis-plants-proposal/)

Live trackers: Minnesota Revisor bill search (https://www.revisor.mn.gov/bills/), LegiScan Minnesota, and Marijuana Moment.

Support this work

This work is free and reader-funded. No paywalls, no ads. This brief is independent and fully sourced, and reader contributions are what keep the 50-state coverage current and answerable to readers, not advertisers or owners.

If it helped you, please chip in $5 to keep it going. Recurring support helps most; about $25 funds a full refresh of a state brief like this one.

Contribute $5 on Ko-fi Become a member

← Back to all 50 states and federal briefs

A planning snapshot for 2026, not legal advice. Policy moves quickly; confirm any single detail against the cited sources before acting on it. Sponsor names are given where confirmable and marked unconfirmed otherwise.

About the author. Jessica Mantonya is the founder of Drug Policy Watch and Hold in Common. She also advises operators, advocates, and funders on regulatory strategy and anti-enclosure positioning. Work with her →

Sources